160 related articles for article (PubMed ID: 33684337)
21. Brimonidine-associated uveitis - a descriptive case series.
Hopf S; Mercieca K; Pfeiffer N; Prokosch-Willing V
BMC Ophthalmol; 2020 Dec; 20(1):489. PubMed ID: 33334316
[TBL] [Abstract][Full Text] [Related]
22. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Tsujinaka A; Takai Y; Inoue Y; Tanito M
Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
[No Abstract] [Full Text] [Related]
23. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
[TBL] [Abstract][Full Text] [Related]
24. The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients.
Walter KA; Gilbert DD
Ophthalmology; 2001 Aug; 108(8):1434-8. PubMed ID: 11470696
[TBL] [Abstract][Full Text] [Related]
25. Preservative-free
Duru Z; Ozsaygili C
Cutan Ocul Toxicol; 2020 Mar; 39(1):21-24. PubMed ID: 31615279
[No Abstract] [Full Text] [Related]
26. In vivo, micro-morphological vascular changes induced by topical brimonidine studied by Dynamic optical coherence tomography.
Themstrup L; Ciardo S; Manfredi M; Ulrich M; Pellacani G; Welzel J; Jemec GB
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):974-9. PubMed ID: 26916576
[TBL] [Abstract][Full Text] [Related]
27. Bilateral granulomatous uveitis in an elderly female.
Kattige J; Konana VK; Babu K
Indian J Ophthalmol; 2019 Sep; 67(9):1391. PubMed ID: 31436179
[No Abstract] [Full Text] [Related]
28. Topical brimonidine reduces IPL-induced erythema without affecting efficacy: A randomized controlled trial in patients with facial telangiectasias.
Vissing AE; Dierickx C; Karmisholt KE; Haedersdal M
Lasers Surg Med; 2018 Dec; 50(10):1002-1009. PubMed ID: 29911352
[TBL] [Abstract][Full Text] [Related]
29. A review of neuropsychiatric adverse events from topical ophthalmic brimonidine.
Cimolai N
Hum Exp Toxicol; 2020 Oct; 39(10):1279-1290. PubMed ID: 32347114
[TBL] [Abstract][Full Text] [Related]
30. [Brimonidine (Mirvaso), dermal use].
Van Genechten D
J Pharm Belg; 2015 Jun; (2):45-6. PubMed ID: 26466509
[No Abstract] [Full Text] [Related]
31. Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex.
Kato COS; Shimizu K; Kamiya K; Ishikawa H; Igarashi A
Sci Rep; 2018 Jun; 8(1):9003. PubMed ID: 29899357
[TBL] [Abstract][Full Text] [Related]
32. [Brimonidine-induced interstitial keratitis: Case report].
Szwarcberg L; Gabrielle PH; Guillarme-Sallit R; Creuzot-Garcher C; Arnould L
J Fr Ophtalmol; 2024 Jun; 47(6):104122. PubMed ID: 38479333
[No Abstract] [Full Text] [Related]
33. [Hypotensive effect of three different formulations of brimonidine tartrate in normal eyes].
Abud TB; Scuoteguazza Filho M; Oliveira ES; Abud JF; Prata Junior JA
Arq Bras Oftalmol; 2013; 76(2):69-71. PubMed ID: 23828464
[TBL] [Abstract][Full Text] [Related]
34. Strabismus surgery hemostasis.
Gupta A; Kekunnaya R; Sachdeva V; Rao HL
Ophthalmology; 2012 Mar; 119(3):649-50. PubMed ID: 22385487
[No Abstract] [Full Text] [Related]
35. Effect of brimonidine tartrate 0.15% on scotopic pupil: controlled trial.
Gerente VM; Biondi AC; Barbosa CP; Lottenberg CL; Paranhos A
J Ocul Pharmacol Ther; 2007 Oct; 23(5):476-80. PubMed ID: 17900228
[TBL] [Abstract][Full Text] [Related]
36. Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
Clemente-Tomás R; Arciniegas-Perasso CA; Hervás-Hernandis JM; García-Ibor F; Ruiz-Del Río N; Duch-Samper AM
Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):511-514. PubMed ID: 29910082
[TBL] [Abstract][Full Text] [Related]
37. Increased risk for flap dislocation with perioperative brimonidine use in femtosecond laser in situ keratomileusis.
Muñoz G; Albarrán-Diego C; Sakla HF; Javaloy J
J Cataract Refract Surg; 2009 Aug; 35(8):1338-42. PubMed ID: 19631117
[TBL] [Abstract][Full Text] [Related]
38. Topical brimonidine-assisted laser treatment for the prevention of therapy-related erythema and hyperpigmentation.
Lee SJ; Ahn GR; Seo SB; Park KY; Kim BJ; Nam Kim M
J Cosmet Laser Ther; 2019; 21(4):225-227. PubMed ID: 30235041
[TBL] [Abstract][Full Text] [Related]
39. Postoperative lomefloxacin 0.3% prophylaxis in strabismus surgery.
Snir M; Hasanreisoglu M; Friling R; Goldenberg-Cohen N; Ehrlich R; Bagan J; Axer-Siegel R
Curr Eye Res; 2008 Oct; 33(10):819-25. PubMed ID: 18853315
[TBL] [Abstract][Full Text] [Related]
40. Brimonidine Induced Anterior Uveitis.
Beltz J; Zamir E
Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
